Peyronie's Disease
Also known as: Peyronie disease, Penile fibrosis, Curved penis
Peyronie's disease is a condition in which scar tissue (plaque) forms in the tough sheath surrounding the erectile tissue of the penis. The plaque does not stretch like normal tissue, so during an erection the penis bends, narrows, or develops an indentation at the site of the scar. It typically begins with pain and a gradually developing curve during an active phase that lasts several months, then settles into a stable phase where pain eases but the curvature remains. Peyronie's can make sex difficult or impossible and often causes considerable distress and loss of confidence. It is believed to result from abnormal healing after minor injuries to the penis, and treatments range from injections and traction to surgery, depending on severity and stage.
Last updated November 10, 2026
Understanding Peyronie's Disease
Peyronie's disease is a localized scarring disorder of the tunica albuginea, the tough elastic sheath around the two erectile cylinders of the penis. A fibrous plaque forms, usually on the top surface, and because scar does not stretch, the erect penis bends toward the plaque, shortens, or develops an hourglass waist or hinge. Surveys put the prevalence at 3 to 9 percent of adult men, rising to about 13 percent in some screened populations, with typical onset in the 50s; it is heavily underreported because men do not mention it. About 1 in 5 also has Dupuytren's contracture of the palm, and the two share a tendency to overgrow collagen after minor injury. Diabetes, a history of prostate surgery, low testosterone and smoking are over-represented. The impact is out of proportion to the size of the plaque: in one urology series, 48 percent of men met criteria for clinically significant depression, and about half reported relationship strain.
The accepted trigger is repeated microtrauma to the erect penis during sex, usually unremembered, in a man whose healing response is skewed toward fibrosis. Instead of resolving, a small bleed between layers of the tunica sets off sustained signaling by TGF-beta 1, fibroblasts turn into contractile myofibroblasts, and disorganized collagen is laid down and sometimes calcifies. The disease runs in two phases. The acute or active phase lasts 6 to 18 months and features pain with erection, a changing curve and a tender, evolving plaque. The chronic or stable phase begins when the pain has gone and the curve has not changed for at least 3 months, usually 12 to 18 months from onset. In a prospective series of 246 untreated men, pain resolved in 89 percent, but curvature improved spontaneously in only 12 percent, stayed the same in 40 percent and worsened in 48 percent, which is why waiting is a strategy for the acute phase only. Erectile dysfunction coexists in roughly a third, partly from the plaque interfering with venous closure and partly from fear.
Management is staged, following the American Urological Association (AUA) guideline of 2015. In the acute phase the options are pain control, treating erectile dysfunction, and traction. Once the disease is stable, the best-supported office treatment is intralesional collagenase clostridium histolyticum (Xiaflex), the only FDA-approved drug for Peyronie's: in the IMPRESS I and II trials, 832 men with curvature of 30 to 90 degrees received up to four cycles of two injections plus penile modeling, and mean curvature improved by 34 percent (about 17 degrees) versus 18 percent (9 degrees) with placebo. Intralesional interferon alfa-2b and verapamil are alternatives with weaker evidence. Surgery is for stable disease with a curve that prevents sex: plication for curves under about 60 degrees with good erections, plaque incision and grafting for larger curves or hourglass deformity, and a penile implant when erectile dysfunction is also present. Oral drugs are the weak link: the AUA says clinicians should not offer vitamin E, tamoxifen, procarbazine, omega-3 or vitamin E with L-carnitine, and rates pentoxifylline, colchicine and potaba as unproven.
The honest summary of natural approaches is that the ones men are most likely to buy have been tested and have failed. Vitamin E was the standard oral treatment for 60 years; the largest placebo-controlled trial, 236 men followed for 6 months, found no effect on curvature, plaque size or pain from vitamin E, propionyl-L-carnitine or the two together, and the AUA guideline now advises against it. Potassium para-aminobenzoate (potaba) prevented progression but did not reduce an existing curve in a 12-month trial of 103 men, is expensive and causes nausea in many. Omega-3 failed in a 224-man trial. Coenzyme Q10 and acetyl-L-carnitine each have one small positive trial that has never been replicated. Nothing applied to the skin reaches the plaque in meaningful concentration, which disposes of vitamin E oils and 'plaque-dissolving' creams. Where a natural approach helps is as a low-risk holding measure in the acute phase while you wait for stability, alongside the things trials do support: traction, which is mechanical rather than nutritional, and treating the anxiety and avoidance that make everything worse.
The most common mistake is waiting in silence. Men typically delay 12 to 18 months before seeing anyone, and by then the window in which traction can preserve length has largely closed and the curve has set; a urologist seen in the first months can document the curve with a photograph or an in-office erection test, rule out other causes of a lump, and start traction or pain management. The second mistake is confusing Peyronie's with a penile fracture. A sudden snap or pop during sex followed by immediate pain, loss of erection, swelling and bruising is a torn tunica albuginea, not a plaque forming; it needs an emergency department within hours, because surgical repair within 24 hours gives the best chance of avoiding permanent curvature and erectile dysfunction. The third is pursuing surgery during the active phase: operating on a still-changing curve risks recurrence, which is why every guideline requires at least 3 months of stable curvature, and usually 12 months from onset, before plication or grafting.
At a Glance
- Common symptoms
- A hard lump or band of tissue that can be felt under the skin of the penis, A curve, bend, or hourglass narrowing of the penis during erection, Pain in the penis, with or without an erection, especially in the early active phase
- Main treatments
- Observation during the active phase, since surgery is not performed until the condition has been stable for several months, Collagenase injections (Xiaflex) into the plaque, which break down scar tissue and reduce curvature in suitable candidates, Penile traction therapy using a device worn daily, which can reduce curvature and preserve length
- Category
- Reproductive · More common than once thought, particularly in middle-aged men; often underreported
- See a doctor if
- A new lump, curve, or indentation in the penis
Symptoms
Causes
- Abnormal wound healing after repeated minor trauma to the erect penis during sex or sport, often not remembered
- Formation of fibrous scar tissue in the tunica albuginea, the sheath around the erectile chambers
- A genetic predisposition to abnormal scarring
- Association with connective tissue disorders such as Dupuytren's contracture of the hand
Risk Factors
- Middle age, with most diagnoses between 40 and 70
- A family history of Peyronie's disease or Dupuytren's contracture
- Diabetes and erectile dysfunction
- Previous prostate surgery
- Smoking and a history of pelvic or penile trauma
Diagnosis
- A history of symptoms, timing, and effect on sexual function
- Physical examination to feel the plaque and assess its location and size
- Assessment of the curvature, sometimes using photographs taken at home during erection or an injection-induced erection in clinic
- Penile ultrasound to map the plaque and check blood flow
- Screening for erectile dysfunction and psychological distress
Treatment
- Observation during the active phase, since surgery is not performed until the condition has been stable for several months
- Collagenase injections (Xiaflex) into the plaque, which break down scar tissue and reduce curvature in suitable candidates
- Penile traction therapy using a device worn daily, which can reduce curvature and preserve length
- Oral medications for pain or erectile dysfunction; drugs such as pentoxifylline have limited evidence for the plaque itself
- Surgery for stable, significant curvature: plication (shortening the longer side), grafting of the plaque, or penile implant when erectile dysfunction coexists
- Supportive: counseling or sex therapy to address distress and help couples adapt
- Supportive: vitamin E and other supplements have been widely used but trials show little benefit; discuss before trying
Natural remedies for peyronie's disease: what the evidence says
Ranked by the strength of human evidence for peyronie's disease specifically. These sit alongside medical care, not in place of it.
CoQ10 (Ubiquinone)
Preliminary evidenceIn a single 24-week randomized trial of 186 men with early Peyronie's disease, 300 mg of coenzyme Q10 daily reduced mean curvature from about 31 to 24 degrees and shrank plaque volume, while placebo-treated men worsened; erectile function scores also improved. This is the only trial, it came from one research group whose body of work has since drawn scrutiny, and no independent study has reproduced it, so the AUA lists CoQ10 among treatments with insufficient evidence.
- Studied dose
- 300 mg coenzyme Q10 daily with a fat-containing meal for 24 weeks in the trial.
- Cautions
- May reduce the effect of warfarin; can cause mild stomach upset or insomnia if taken late. It is not a substitute for assessment, and tell your urologist you are taking it before collagenase injections or surgery.
Acetyl-L-Carnitine (ALCAR)
Preliminary evidenceA 3-month trial of 48 men compared acetyl-L-carnitine 1 g twice daily with tamoxifen and found more pain relief and a mean curvature reduction of about 10 degrees with carnitine, with fewer side effects. However, the larger and better-designed 236-man trial that tested propionyl-L-carnitine, a related form, alone or with vitamin E found no benefit on any outcome, and the AUA guideline recommends against the vitamin E plus L-carnitine combination. Treat the positive result as unconfirmed.
- Studied dose
- 1 g acetyl-L-carnitine twice daily for 3 months in the positive trial.
- Cautions
- Can cause fishy body odor, nausea and restlessness, and may increase the effect of warfarin and of thyroid hormone. People with seizure disorders should avoid it.
What matters day to day
- Photograph the erect penis from above and from the side within the first weeks and again every 2 to 3 months: a dated record lets a urologist judge whether the curve is still changing, which decides whether you are in the acute or stable phase and which treatments are on the table.
- If you use traction, commit to it: in the RestoreX randomized trial, 30 to 90 minutes a day for 3 months improved curvature by about 12 degrees and length by 1.5 cm, and older devices needed 3 to 8 hours a day to show any effect; a device used for 10 minutes twice a week does nothing.
- Treat erectile dysfunction rather than pushing through: a partially rigid penis buckles, and buckling is the injury that started the plaque; PDE5 inhibitors are safe in Peyronie's and may reduce re-injury.
- Use plenty of lubricant and, during the acute phase, avoid positions where a partner's weight bears down on the shaft, since partner-on-top is the most common setting for buckling injuries.
- Stop smoking and keep A1c under control if you have diabetes: both impair tissue healing and are over-represented in Peyronie's, and diabetic men have more severe curvature and worse surgical outcomes.
- Talk to your partner and, if sex has stopped, consider a few sessions with a sex therapist: nearly half of men with Peyronie's screen positive for depression, avoidance is the most common reason couples stop having sex, and distress improves even when the curve does not.
Prevention
- Peyronie's cannot be reliably prevented
- Take care during vigorous sex to avoid bending injuries to the erect penis
- Treat erectile dysfunction, since a partially rigid penis is more vulnerable to buckling injuries
- Keep diabetes well controlled and do not smoke
- Seek assessment early when a curve or lump appears, since early treatment options differ from late ones
When to See a Doctor
- A new lump, curve, or indentation in the penis
- Pain with erections lasting more than a few weeks
- Curvature that makes sex difficult or painful
- Sudden severe pain, bruising, and swelling of the penis after a 'popping' sensation during sex (emergency, possible penile fracture)
- Significant distress or relationship strain related to the condition
Frequently Asked Questions
References
- Nehra A, Alterowitz R, Culkin DJ, et al.. Peyronie's disease: AUA guideline. Journal of Urology (2015)
- Gelbard M, Goldstein I, Hellstrom WJ, et al.. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. Journal of Urology (2013)
- Mulhall JP, Schiff J, Guhring P. An analysis of the natural history of Peyronie's disease. Journal of Urology (2006)
- Safarinejad MR, Hosseini SY, Kolahi AA. Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: a double-blind, placebo controlled, randomized study. Journal of Urology (2007)
- Weidner W, Hauck EW, Schnitker J. Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized study. European Urology (2005)
- Ziegelmann M, Savage J, Toussi A, et al.. Outcomes of a novel penile traction device in men with Peyronie's disease: a randomized, single-blind, controlled trial. Journal of Urology (2019)
- Safarinejad MR. Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie's disease: a double-blind, placebo-controlled randomized study. International Journal of Impotence Research (2010)
- Biagiotti G, Cavallini G. Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report. BJU International (2001)
- Nelson CJ, Diblasio C, Kendirci M, Hellstrom W, Guhring P, Mulhall JP. The chronology of depression and distress in men with Peyronie's disease. Journal of Sexual Medicine (2008)
- National Institute of Diabetes and Digestive and Kidney Diseases. Penile Curvature (Peyronie's Disease) (2019)View source
Related Conditions
Have questions about Peyronie's Disease?
Ask Mother Nature AI for personalized, evidence-based guidance.
Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.
Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.